Trade Mark Journal No.2026/002 9 January 2026

WO0000001892856 (42)

Office of origin: United States of America

Date of International Registration:31 July 2025
Date of designation in the UK: 31 July 2025
Image for mark 1892856 CYTOSCRIBE

International priority date claimed: 18 February 2025 (United States of America) (99045524)
Class 42
Providing online non-downloadable computer software platforms for scientific research; providing online non-downloadable computer software platforms for use in molecular biology; providing online non-downloadable computer software platforms for in biotechnology research; providing online non-downloadable computer software platforms for cell cycle analysis; providing online non-downloadable computer software platforms for gene expression profiling; providing online non-downloadable computer software platforms for cell sorting; providing online non-downloadable computer software platforms for protein expression; providing online non-downloadable computer software platforms for import and analyze data; providing online non-downloadable computer software platforms for database management; providing online non-downloadable computer software platforms for organizing and managing experiments; providing online non-downloadable computer software platforms for analysis of scientific data and information for use in analyzing cells and particles using reflective and fluorescent properties produced by a flow cytometer apparatus or device.

BioLegend, Inc.

Representative: Kevin Oliver Revvity, Inc., 77 4th Avenue, Floor 2, Waltham MA 02451, UNITED STATES OF AMERICA